Help | RSS Feed

Genetic Technologies Ltd. (NASD:GENE) Seasonal Chart

GENE Relative to the S&P 500
GENE Relative to the S&P 500

GENE Relative to the Sector
GENE Relative to the Sector

Monthly Seasonal Genetic Technologies Ltd. (NASD:GENE)

Seasonal Chart Analysis

Analysis of the Genetic Technologies Ltd. (NASD:GENE) seasonal charts above shows that a Buy Date of January 1 and a Sell Date of March 25 has resulted in a geometric average return of 10.83% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 44.73% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Genetic Technologies Ltd is a molecular diagnostics company which offers predictive testing and assessment tools to help physicians manage women?s health. It has developed BREVAGenplus, which is a is a clinically validated risk assessment test.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore